{"count": 1, "results": [{"_id": "38070031", "pmid": 38070031, "title": "The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial.", "journal": "J Neurol", "authors": ["Abdelgaied MY", "Rashad MH", "El-Tayebi HM", "Solayman MH"], "date": "2023-12-09T00:00:00Z", "doi": "10.1007/s00415-023-12113-2", "meta_date_publication": "2023 Dec 9", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.11, "text_hl": "We aimed to investigate the efficacy and safety of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an adjuvant therapy to interferon beta 1a (IFNbeta-1a) in @<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@relapsing-remitting multiple sclerosis@@@ (@<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@RRMS@@@) @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Abdelgaied MY, Rashad MH, El-Tayebi HM, Solayman MH. The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial. J Neurol. 2023 Dec 9;():. PMID: 38070031", "BibTeX": "@article{38070031, title={The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial.}, author={Abdelgaied MY and Rashad MH and El-Tayebi HM and Solayman MH}, journal={J Neurol}}"}}]}